We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Optimisation of Cardiac Resynchronisation Therapy by Non-invasive Cardiac Output - The CHOICE2 Study (CHOICE2)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2010 by University of Dundee.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01055210
First Posted: January 25, 2010
Last Update Posted: January 25, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Dundee
  Purpose
An evaluation of the role of resting and exercise cardiac output measurement, by the inert gas rebreathing method, in optimisation of patients with cardiac resynchronisation pacemakers.

Condition Intervention
Heart Failure Cardiac Resynchronisation Pacemakers Device: Optimisation of VV delay

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Optimisation of Cardiac Resynchronisation Therapy by Non-invasive Cardiac Output - The CHOICE2 Study

Further study details as provided by University of Dundee:

Primary Outcome Measures:
  • 6 minute hall walk test [ Time Frame: 4 months ]

Secondary Outcome Measures:
  • Echocardiographic measures of desynchrony [ Time Frame: 3 months ]

Estimated Enrollment: 40
Study Start Date: February 2010
Estimated Study Completion Date: February 2011
Estimated Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Optimisation of VV delay
    Programmed VV delay altered on device
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Cardiac Resynchronization Device in situ for Heart Failure

Exclusion Criteria:

  • Unable to cope with mouthpiece
  • Estimated life expectancy < 6 months
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01055210


Locations
United Kingdom
University of Dundee Not yet recruiting
Dundee, United Kingdom
Contact: Anna Maria Choy    01382 632108    a.choy@dundee.ac.uk   
Principal Investigator: Anna Maria Choy         
Sponsors and Collaborators
University of Dundee
Investigators
Principal Investigator: Anna- Maria Choy University of Dundee
  More Information

Responsible Party: Dr. Anna Maria Choy, University of Dundee
ClinicalTrials.gov Identifier: NCT01055210     History of Changes
Other Study ID Numbers: ELD002
First Submitted: January 22, 2010
First Posted: January 25, 2010
Last Update Posted: January 25, 2010
Last Verified: January 2010

Keywords provided by University of Dundee:
Heart Failure
Pacemakers

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases